The ISPE Chesapeake Bay Area Chapter Mid-Atlantic Science & Technology (MAST) Virtual Showcase, hosted on May 19th, 2021, provided a platform for life science companies to discuss strategies for addressing challenges in the life science industry.
Maryland’s reputation as the destination state for biotech jobs and life science research continues to climb as new startups emerge across its biohealth cluster regions.
While the pandemic has forced many industries to downsize, biotech companies have had the opportunity — or sometimes the obligation — to ramp up. Just take a look at Catalent Pharma Solutions, the Baltimore-based contract manufacturer. The company has hired over 500 new employees since last March, said Talent Acquisition Specialist Charle’ Lamb during a panel at the Biohealth Industry Day.
Montgomery College’s Bio-Trac Biotechnology Program Offering Rigorous Life Science Professional Development Lineup this Spring and Fall
Bio-TracⓇ is a leading biotechnology-focused professional development and workforce training program located at Montgomery College’s Bioscience Education Center (BEC). The program nurtures and supports the BioHealth Capital Region (BHCR) talent pipeline as well as national and international academic, government, and private research institutions.
Lonza Pharma and Biotech (Lonza) is one of the world’s leading contract development and manufacturing organizations with 37 sites across the U.S., Europe, Asia, and the Middle East.
“What was impossible yesterday is possible today.” Those were the words Dr. Gail Wasserman, Senior Vice President, Biopharmaceutical Development, R&D at AstraZeneca shared with faculty, staff, and students during this week’s PIC MC “Office Hours with the Experts” program.
Rockville, Maryland’s Advanced BioScience Laboratories, Inc. (ABL) is a rapidly growing biotech company that provides expert contract manufacturing and laboratory research services to customers across the globe. The company delivers best-in-class GMP manufacturing and immunology solutions for gene therapies, oncolytics, vaccines, and other immunotherapeutics to life science organizations, and government agencies.
COVID-19 has created significant challenges for the Venture Capital (VC) market and life science companies seeking funding during the pandemic. While the pandemic has undoubtedly added a new layer of risk to an inherently risky field, the fundamentals for what makes a company attractive to a VC have remained steady.
The Sixth Annual BioHealth Capital Region Forum brought together industry leaders from across the region who discussed the accomplishments and strengths of the region as its member companies continue to innovate new therapies and medicines in one of the strongest bio-hub regions in the United States.
The COVID-19 Pandemic didn’t stop the Maryland Tech Council from holding their 32nd Annual Industry awards. Taking this event online, MTC continued via a live virtual broadcast to recognize the top Life Sciences and Tech Companies in Maryland.